These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27138956)

  • 1. Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.
    Umegaki H
    Drugs Aging; 2016 Jun; 33(6):399-409. PubMed ID: 27138956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study.
    Samaras K; Makkar S; Crawford JD; Kochan NA; Wen W; Draper B; Trollor JN; Brodaty H; Sachdev PS
    Diabetes Care; 2020 Nov; 43(11):2691-2701. PubMed ID: 32967921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
    Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
    J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Fasting Blood Glucose Level Increases the Risk of Cognitive Decline Among Older Adults with Diabetes Mellitus: The Shanghai Aging Study.
    Wang F; Luo J; Ding D; Zhao Q; Guo Q; Liang X; Zhou F; Deng W; Hong Z
    J Alzheimers Dis; 2019; 67(4):1255-1265. PubMed ID: 30689569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes mellitus and cognitive disorders from the diabetologists perspective].
    Šmahelová A
    Vnitr Lek; 2017; 63(10):717-720. PubMed ID: 29127756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways.
    Green H; Tsitsi P; Markaki I; Aarsland D; Svenningsson P
    CNS Drugs; 2019 Feb; 33(2):143-160. PubMed ID: 30687888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.
    Rawlings AM; Sharrett AR; Mosley TH; Ballew SH; Deal JA; Selvin E
    Diabetes Care; 2017 Jul; 40(7):879-886. PubMed ID: 28500217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction: an emerging concept of a new diabetic complication in the elderly.
    Umegaki H; Hayashi T; Nomura H; Yanagawa M; Nonogaki Z; Nakshima H; Kuzuya M
    Geriatr Gerontol Int; 2013 Jan; 13(1):28-34. PubMed ID: 22882533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Antidiabetic Drugs in Treating Dementia: A Peek into Pharmacological and Pharmacokinetic Properties.
    Ogura J; Yamaguchi H
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes as a risk factor for cognitive impairment: current insights.
    Umegaki H
    Clin Interv Aging; 2014; 9():1011-9. PubMed ID: 25061284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
    Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
    Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cognitive impairment in diabetes mellitus: are prevention and treatment effective?
    Zavoreo I; Madžar Z; Demarin V; Kes VB
    Acta Clin Croat; 2014 Sep; 53(3):326-33. PubMed ID: 25509243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of butylphthalide on cognitive decline in diabetic rats.
    Tian Z; Wang J; Wang Y; Zhang M; Zhou Y
    Mol Med Rep; 2017 Dec; 16(6):9131-9136. PubMed ID: 28990110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive Dysfunction in Older Adults with Type 2 Diabetes: Links, Risks, and Clinical Implications.
    Sinclair A; Abdelhafiz A
    Clin Geriatr Med; 2020 Aug; 36(3):407-417. PubMed ID: 32586471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current approaches to management of patients with mild cognitive impairment].
    Zakharov VV; Gromova DO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):107-112. PubMed ID: 28399106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus and cognitive impairment].
    Surkova EV; Tanashyan MM; Bespalov AI; Naminov AV
    Ter Arkh; 2019 Oct; 91(10):112-118. PubMed ID: 32598641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders.
    Cha DS; Vahtra M; Ahmed J; Kudlow PA; Mansur RB; Carvalho AF; McIntyre RS
    Curr Mol Med; 2016; 16(5):465-73. PubMed ID: 27132792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.